Leading Life Science Innovation
Discover the future of omics with MGI's Next-Generation Sequencing: ultra-high throughput, scalability, and speed. Enhance your research with precision sequencing, advanced automation, and integrated bioinformatics, expanding the possibilities in genomics.
Leading with innovation to all Sequencing Industry Explorers
Sequencing platforms
Unlock the full potential of your sequencing projects with our innovative DNBSEQ™ technology, designed for superior accuracy and efficiency. Paired with the robust performance of our next-generation sequencing (NGS) platforms, this unique combination ensures exceptional results for all genomic research needs.
Laboratory automation
With decades of expertise in next-generation sequencing (NGS), we've developed proprietary laboratory automation platforms, designed for scalability and adaptability. Our innovative lab automation systems are engineered to be versatile, enabling commercialization across a wide range of applications, from clinical diagnostics to genomics research.
Bioinformatics software
Leveraging advanced bioinformatics tools, computational methods, and cutting-edge sequencing technologies, MGI enables comprehensive analysis of biological data, uncovering insights into genetics data and driving advancements in multiomics and biotechnology.
Novel Products
Enhance your sequencing capabilities with our innovative multiomics solutions. We combine advanced DNBSEQ™ sequencing chemistry with the proven performance of our cutting-edge NGS, Stereo-Seq and Single-cell platforms to deliver unmatched precision and seamless data integration across genetic studies.
Operating in 100+ countries with 2,900+ users, MGI's technology supports 781+ valid patent applications and over 60 petabytes of data generation with T series sequencers.
2860+
Employees Worldwide, including 33.4% in R&D, with 9 R&D centers, 7 production centers, and 10+ CEC labs.
7500+
Papers published in top scientific journals, including 900+ in CNS, Lancet, and other core journals based on the DNBSEQ platform.
In the science journal
When Genomics meets Metabolomics by Circulating Metabolites in Blood
Genomics
Oct 2, 2024
Exploring the intersection of genomics and metabolomics to uncover genetic links with metabolic diseases like diabetes, obesity, and cardiovascular disorders.
